Jeunesse Global has been able to rise from an obscure startup that was founded out of the garage of a retired Florida couple into one of the most important players on the global health and beauty scene. And it has accomplished this incredible growth in just over 9 years. Founded in September of 2009 by industry veterans Randy Ray and Wendy Lewis, Jeunesse Global has experienced exponential growth in every year of its existence. Today, the company is valued at more than $1 billion and does hundreds of millions of dollars in sales each year. It has millions of global customers and thousands of distributors, making it a force to be reckoned with across the planet.
But Jeunesse Global had humble beginnings. Founders Randy Ray and Wendy Lewis were looking for a simple way to pass their newly found free time in retirement. The couple had retired just a few weeks prior to the founding of Jeunesse Global, thinking that they would be able to easily make the transition from workaholic entrepreneurs to a life of idleness. But they soon found out that they were mistaken. Ray and Lewis missed the action and strong sense of meaning that came with running their own business.
It didn’t take long for the couple to dive headlong into the running of Jeunesse Global. Soon, Ray and Lewis were spending more than 60 hours each week on growing their fledgling company. Jeunesse Global quickly took off, growing exponentially and creating some of the best products that the health and beauty industry has ever seen.
One of those products is the company’s foundation and bronzer. Known as NV, the product can hold its own versus any of the competing brands. But where NV really stands apart from the competition is in its ability to stave off the worst effects of aging.
Made with the company’s patented APT-200 molecule, NV is clinically proven to reduce wrinkles, prevent the formation of new wrinkles and restore skin elasticity that has been naturally lost to the aging process. It can erase years off a user’s apparent age, helping them look their best.
Sussex Healthcare recently appointed Amanda Morgan-Taylor as the business’ new CEO. Before even formally being recognized as the CEO, she had already begun work in order to have more time to get to know the company, management, patients, and everything needed. In reference to the recent article on the Sussex Healthcare website, “she has already begun to make a real difference”.
Sussex Healthcare is a care home company located in Horsham, West Sussex, UK, founded in March 1998. They are an independent business that provides support and aid for the elderly, including those suffering with dementia and others, as well as adults with any difficulties, whether they are physical or learning based. Their 20 homes house patients who are properly accommodated for and are provided support 24/7.
The behavior that sets Sussex Healthcare apart from other homes is that they take the time to really understand a patient with both social and recreational programs to help them in various ways. This kind of tactic of course promotes good health and the patients feel at ease with the leisure time. In an article by Release Fact, they state “Respect for the individuality of each patient provides an opportunity for the staff to match previous interests such as taking quizzes, dancing, crafting, cooking and reminiscing with current abilities.” This offers the patients quality self-expression time and helps them create new memories and build new skills.
According to glassdoor.co.uk, Ms. Morgan-Taylor already has over 30 years of experience working in the medical field outside of Sussex Healthcare. Her longstanding medical career has grown since she became a certified Mental Health Nurse long ago, including taking on challenging leadership positions. Because of her successful career in several different medical sectors, she has a fine understanding of practices and experience in facing challenges.
Appointing Ms. Morgan-Taylor, a particularly experienced and understanding individual was a great move for the company. Sussex Healthcare is very excited upon this decision, commenting, “This is an exciting and important appointment for the organization, and is further evidence of Sussex Health Care’s commitment to providing high quality care at all of our homes and services in 2018 and beyond.”
Large media outlets and scientific journals have recently been abuzz with the discussion of Elysium Health’s first product, Basis. Many of the company’s reviewers have requested information about the product, its purposes, and the claims made about it by Elysium representatives. These questions can be sufficiently answered by reviewing the large amount of information about the product located on the company’s website. Elysium Health has included the supplement’s purpose, intended results when taken consistently, FDA regulatory information, price points for a subscription, and the results from a clinical trial that test subjects participated in to review the product. Here are the most significant elements of Elysium Health’s first product, Basis.
Basis is a dietary supplement that has been designed to help promote health at the cellular level. The expert scientists at Elysium Health based the development of this product on several years of prior research regarding the coenzyme NAD+. NAD+ is a coenzyme used in many cellular processes, from energy production to circadian rhythm regulation, and it’s present in all living cells. As humans age, NAD+ levels can decrease significantly. The depletion of the NAD+ compound can subsequently affect the processes it is present in. That’s where Basis comes in. Basis utilizes two primary ingredients to increase the levels of NAD+ in the body, thus affecting the cellular processes in which NAD+ is present.
Basis is sold in containers that include 30 capsules each. While consumers can purchase the supplement in its single container form, it can also be ordered in bulk or in a monthly subscription plan. On Elysium Health’s website, consumers can make arrangements for the dietary supplement to be delivered as a one-time, single purchase for $60, a monthly delivery for $50 per month, a 6-month delivery for $270, or a year-long delivery for $480. Deliveries can also be scheduled for more than one bottle of the Basis supplement to be delivered each month.
When taken consistently and as instructed (Elysium recommends taking two capsules each day with or without food), Basis is intended to support cellular health. Internally, the consistent use of the Basis formula should increase NAD+ levels, as demonstrated in a clinical trial conducted by the company earlier this year. Basis customers have already taken to Elysium’s testimonial page to leave stories about their use of the Basis supplement.